SOCS2 Is Critical for the Balancing of Immune Response and Oxidate Stress Protecting Against Acetaminophen-Induced Acute Liver Injury

Acetaminophen (APAP) is usually safe when administrated in therapeutic doses; however, APAP overdose can lead to severe liver injury. APAP can cause direct hepatocyte damage, and stimulates an inflammatory response leading to oxidative stress. Supressor of Cytokine Signaling (SOCS) 2 modulates cytokine and growth factor signaling, and plays a role in the regulation of hepatic cellular processes. Our study evaluated the role of SOCS2 in APAP liver injury. The administration of a toxic dose (600 mg/kg) of APAP caused significant liver necrosis in WT mice. In SOCS2−/− mice, there was significantly more necrosis, neutrophil recruitment, and expression of the neutrophil-active chemokine CXCL-1. Expression of proinflammatory cytokines, such as TNF-α and IL-6, was elevated, while expression of anti-inflammatory cytokines, IL-10 and TGF-β, was diminished. In vitro, SOCS2−/− hepatocytes expressed more p-NF-kB and produced more ROS than WT hepatocytes when exposed to APAP. SOCS2−/− hepatocytes were more sensitive to cell death in the presence of IL-6 and hydrogen peroxide. The administration of catalase in vitro and in vivo resulted in a pronounced reduction of cells/mice death and necrosis in the SOCS2−/− group. We have demonstrated that SOCS2 has a protective role in the liver by controlling pro-oxidative and inflammatory mechanisms induced by APAP.

[1]  H. Tanowitz,et al.  Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria , 2016, Brain, Behavior, and Immunity.

[2]  R. Masuzaki,et al.  SOCS2 Balances Metabolic and Restorative Requirements during Liver Regeneration* , 2015, The Journal of Biological Chemistry.

[3]  Mauro M Teixeira,et al.  Imaging liver biology in vivo using conventional confocal microscopy , 2015, Nature Protocols.

[4]  W. M. Leevy,et al.  Hepatic DNA deposition drives drug‐induced liver injury and inflammation in mice , 2015, Hepatology.

[5]  D. Ye,et al.  SOCS signaling in autoimmune diseases: Molecular mechanisms and therapeutic implications , 2014, European journal of immunology.

[6]  D. Naisbitt,et al.  Idiosyncratic Adverse Drug Reactions: Current Concepts , 2013, Pharmacological Reviews.

[7]  R. Resende,et al.  Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity , 2013, Cell Communication and Signaling.

[8]  K. Shianna,et al.  Limited contribution of common genetic variants to risk for liver injury due to a variety of drugs , 2012, Pharmacogenetics and genomics.

[9]  D. C. Cara,et al.  Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure , 2012, Hepatology.

[10]  M. Lisanti,et al.  Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease. , 2012, The American journal of pathology.

[11]  G. Norstedt,et al.  SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high‐fat‐diet‐fed mice , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  M. Teixeira,et al.  A Model of DENV-3 Infection That Recapitulates Severe Disease and Highlights the Importance of IFN-γ in Host Resistance to Infection , 2012, PLoS neglected tropical diseases.

[13]  Hartmut Jaeschke,et al.  Acetaminophen hepatotoxicity and repair: the role of sterile inflammation and innate immunity , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[14]  Michael P Holt,et al.  The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice. , 2010, Toxicology letters.

[15]  W. Schmidt-Heck,et al.  Heterogeneous expression of suppressor of cytokine signalling 2 (SOCS‐2) in liver tissue , 2009, Journal of anatomy.

[16]  Christian Trautwein,et al.  Inflammatory Pathways in Liver Homeostasis and Liver Injury , 2009, Clinical reviews in allergy & immunology.

[17]  Neil Kaplowitz,et al.  Role of JNK Translocation to Mitochondria Leading to Inhibition of Mitochondria Bioenergetics in Acetaminophen-induced Liver Injury* , 2008, Journal of Biological Chemistry.

[18]  E. Schiff,et al.  Acetaminophen safety and hepatotoxicity – where do we go from here? , 2007, Expert opinion on drug safety.

[19]  M. Jamaluddin,et al.  TNF-α-induced NF-κB/RelA Ser276 phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway , 2007 .

[20]  H. Jaeschke,et al.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity: Another perspective , 2007, Hepatology.

[21]  M. Kubo,et al.  Overexpression of Suppressor of Cytokine Signaling-3 in T Cells Exacerbates Acetaminophen-Induced Hepatotoxicity1 , 2007, The Journal of Immunology.

[22]  J. Tavernier,et al.  Functional Cross-modulation between SOCS Proteins Can Stimulate Cytokine Signaling* , 2006, Journal of Biological Chemistry.

[23]  Neil Kaplowitz,et al.  Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. , 2006, JAMA.

[24]  N. Kaplowitz,et al.  Neutrophil depletion protects against murine acetaminophen hepatotoxicity , 2006, Hepatology.

[25]  N. Perkins,et al.  Good cop, bad cop: the different faces of NF-κB , 2006, Cell Death and Differentiation.

[26]  Richard G. Jenner,et al.  Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Norstedt,et al.  Negative regulation of growth hormone receptor signaling. , 2006, Molecular endocrinology.

[28]  J. Johndrow,et al.  Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent , 2006, Nature Medicine.

[29]  J. Johnston,et al.  SOCS2 Can Enhance Interleukin-2 (IL-2) and IL-3 Signaling by Accelerating SOCS3 Degradation , 2005, Molecular and Cellular Biology.

[30]  K. Rakesh,et al.  Controlling cytokine signaling by constitutive inhibitors. , 2005, Biochemical pharmacology.

[31]  A. Sanabria,et al.  Randomized controlled trial. , 2005, World journal of surgery.

[32]  N. Kaplowitz,et al.  Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. , 2004, Gastroenterology.

[33]  Werner Müller,et al.  Interleukin 6/gp130‐dependent pathways are protective during chronic liver diseases , 2003, Hepatology.

[34]  J. Brady,et al.  Expression profiling of acetaminophen liver toxicity in mice using microarray technology. , 2001, Biochemical and biophysical research communications.

[35]  W. Alexander,et al.  Gigantism in mice lacking suppressor of cytokine signalling-2 , 2000, Nature.

[36]  Warren S. Alexander,et al.  A family of cytokine-inducible inhibitors of signalling , 1997, Nature.

[37]  S. Nelson Molecular Mechanisms of the Hepatotoxicity Caused by Acetaminophen , 1990, Seminars in liver disease.

[38]  Steven D. Cohen,et al.  Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. , 1988, Toxicology and applied pharmacology.

[39]  F. Tietze Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.

[40]  W. J. Racz,et al.  Inhibition of mitochondrial respiration in vivo is an early event in acetaminophen-induced hepatotoxicity , 2007, Archives of Toxicology.

[41]  A. Larson Acetaminophen hepatotoxicity. , 2007, Clinics in liver disease.

[42]  J. Aliberti,et al.  Impact of lipoxin-mediated regulation on immune response to infectious disease , 2006, Immunologic research.

[43]  N. Perkins,et al.  Good cop, bad cop: the different faces of NF-kappaB. , 2006, Cell death and differentiation.

[44]  Roger Kurlan,et al.  Current Concepts , 2022 .